EH1.3 EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine versus lomustine in patients with first progression of a glioblastoma | Zendy

AI Assistant Blog Pricing

EH1.3 EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine versus lomustine in patients with first progression of a glioblastoma

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.